RR

1,204.5

+7.79%↑

BATS

4,313

-2.82%↓

BAE

2,267

+4.04%↑

REL

2,465

+0.24%↑

AAL

3,323

+4.53%↑

RR

1,204.5

+7.79%↑

BATS

4,313

-2.82%↓

BAE

2,267

+4.04%↑

REL

2,465

+0.24%↑

AAL

3,323

+4.53%↑

RR

1,204.5

+7.79%↑

BATS

4,313

-2.82%↓

BAE

2,267

+4.04%↑

REL

2,465

+0.24%↑

AAL

3,323

+4.53%↑

RR

1,204.5

+7.79%↑

BATS

4,313

-2.82%↓

BAE

2,267

+4.04%↑

REL

2,465

+0.24%↑

AAL

3,323

+4.53%↑

RR

1,204.5

+7.79%↑

BATS

4,313

-2.82%↓

BAE

2,267

+4.04%↑

REL

2,465

+0.24%↑

AAL

3,323

+4.53%↑

Search

Galliford Try PLC

Abierto

495 3.77

Resumen

Variación precio

24h

Actual

Mínimo

467.5

Máximo

496

Métricas clave

By Trading Economics

Ingresos

18M

Ventas

-17M

935M

P/B

Media del Sector

14.286

57.257

BPA

0.17

Rentabilidad por dividendo

3.92

Margen de beneficios

1.947

Empleados

4,317

EBITDA

-1.4M

34M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+37.17% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.92%

2.27%

Fecha Próximo Dividendo

10 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-34M

492M

Apertura anterior

491.23

Cierre anterior

495

Galliford Try PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 mar 2026, 23:31 UTC

Acciones populares

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Ganancias

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 abr 2026, 00:00 UTC

Adquisiciones, fusiones, absorciones

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Ganancias

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Charlas de Mercado
Ganancias

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Charlas de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Charlas de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Ganancias

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Ganancias

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Ganancias

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Ganancias

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Ganancias

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Charlas de Mercado
Ganancias

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Ganancias

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Ganancias

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Ganancias

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Ganancias

Nike CEO: Converse Remains Important to Portfolio

Comparación entre iguales

Cambio de precio

Galliford Try PLC previsión

Precio Objetivo

By TipRanks

37.17% repunte

Estimación a 12 Meses

Media 655 GBX  37.17%

Máximo 670 GBX

Mínimo 650 GBX

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Galliford Try PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Galliford Try PLC

Galliford Try Holdings plc, together with its subsidiaries, operates in the construction business in the United Kingdom. It operates through Building, Infrastructure, and PPP Investments segments. The company engages in the construction of buildings for private and public sector clients in health, education, custodial, and defense markets, as well as serves commercial clients. It also builds, designs, and maintains highways and environment related construction. In addition, the company operates building projects through public-private partnerships and co-development opportunities. Galliford Try Holdings plc was incorporated in 2019 and is based in Uxbridge, the United Kingdom.
help-icon Live chat